Aubrey works on the development of medical innovations that can postpone all forms of age-related ill-health. His main focus is on rejuvenation: that is, the active repair of the various types of molecular and cellular damage which eventually cause age-related disease and disability, as opposed to the mere retardation of the accumulation of such damage. Aubrey performs this work in the capacity as chief science officer of SENS Research Foundation, a California-based 501(c)(3) charity that undertakes and funds such research; as VP of New Technology Discovery of AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology; and also as editor-in-chief of Rejuvenation Research, the highest-impact peer-reviewed academic journal focused on postponing aging.
Nir Barzilai MD
Director, Institute for Aging Research at the Albert Einstein College of Medicine, PI: Nathan Shock Center of Excellence in the Biology of Aging PI: Glenn Center for the Biology of Human Aging. Co-Scientific Director of the American Federation for Aging Research Founder and on the Board of CohBar Inc. Chief Medical Advisor for Life Bioscience
Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging and the principal investigator of the Einstein Nathan Shock Center and the Glenn center. He was the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. Dr. Barzilai is on the board of AFAR, its scientific director and a founding member of the Academy for Lifespan and Health span. He co-founded CohBar and Lifebioscinces. He has been featured in major papers, TV program and documentaries (2 TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, Prime Minister office in Israel, several International Banks, The Vatican, Pepsico, Milken Institute, Davos Economical Forum, and featured in The Wall Street Journal, New York Times, The Economist and Wired Magazine. His book Age Later was published in the June of 2020.
Dr. Pranjul Shah
Pranjul is driving a systemic mindset change towards entrepreneurship and innovation within the University of Luxembourg ecosystem via tailored entrepreneurship training and mentoring programs. He is a chief mentor to over 35 startups at the incubator pushing them towards successful execution of their entrepreneurial goals. He is an expert jury and mentor on numerous international awards, business plan competitions and hackathons.
He has acquired a PhD in Physics and Nanotechnology from the Technical University of Denmark and Masters from University of Glasgow. During his PhD, he was handpicked as a Kauffman Global Scholar to embark on a 6 month intensive entrepreneurial training fellowship coordinated by the Kauffman Foundation in collaboration with MIT, Stanford University and Harvard University. He is recipient of numerous research and innovation awards including Outstanding Research-Driven Innovation award from National Research Foundation of Luxembourg.
Mika has over 15 years' experience on pharmaceutical market research and register analysis in the Nordic level. Mika is the founder of Success Clinic Holding which owns several research, HealthCare and Wellbeing related companies. Mika works currently as a Managing Director of Success Clinic. Success Clinic works closely with all key Big Pharma companies and several Universities in the Europe. Mika can help with HealthCare marketing, business models and strategies. Mika's specialty is creating business models for Health Care and Health Data.
Giuseppe believes that success starts with a great story, in business as in life. His mission is to help visionary entrepreneurs bring their innovation to the world.
He is the founder of Chiaro, of communications agency for Health & Life Sciences companies preparing for fundraising. His clients went on to raise millions of euros, close high-value deals, and take their business to the next level.
A former scientist-turned-communication pro, Giuseppe has worked with some of the most admired organizations of the sector, from academia and biotech to big pharma. Giuseppe is also pitch coach for Europe’s leading start up accelerators.
And in case you’re wondering, 'Chiaro' is Italian for clear and brilliant.
"Create, Share, Grow", this is how Innovation works. This is how we advance to the future. This is what I believe in - Dreams. I am a passionate thinker, ex-scientist (still one in my soul) and an Innovation professional. Love to play Badminton, photograph, cook and hike and if you have a problem we can brainstorm on - I am all in.
Cumulative experience of 12 years in Healthcare & Life sciences
· Healthcare innovations: Biotech, Digital Health, MedTech, Wellness
· Portfolio management & strategy
· Building partnerships and strategic initiatives
· Business and domain consultancy
Pritam Kumar Panda
Pritam Kumar Panda is pursuing Ph.D. at Department of Physics and Astronomy, Uppsala University, Sweden under the supervision of Prof. Rajeev Ahuja and Prof. Yogendra Kumar Mishra, Professor MSO and Leader of Smart Materials group at Mads Clausen Institute, University of Southern Denmark (SDU), Denmark. He held his double Master’s in Bioinformatics from Utkal University & D.Y. Patil University, India. He had worked as a graduate scientist in the Division of Pediatric Haematology and Oncology, University of Freiburg, Germany.
He is currently associated with KIIT University, India and Karolinska Instituet, Sweden as as a visiting researcher. Recently he has been engaged with Karolinska Institute to develop vaccines for cardiovascular diseases and arthritis. He has published more than 40 papers including many in top ranked journals, such as Science Advances, Nature Leukemia, Inorganic Chemistry (ACS), Adv. Functional Materials (Wiley) etc. and also serves as referee for various reputed journals. His expertise include bioinformatics, computational biology, 2D materials modelling, nano-biotechnology, biophysics and nanomedicine.
His primary topic of research is computational modelling of ZnO tetrapods for bio-sensing applications and quantum technologies with 2D nanostructured materials for energy storage applications.
Noora is building value-based innovations and startups in her position as managing partner at Impact Hub Bern and as board member of Impact Hub Switzerland. Impact Hubs worldwide are the largest network and platform for impact driven entrepreneurs. In Circular Economy Transition program Noora is driving a transformation into the circular economy in Switzerland. She focuses on building businesses which combine long-term financial success with a positive impact on our society and environment. In her PhD she specialized in corporate innovation and entrepreneurship. In her work Noora is taking a holistic perspective combining coaching and program design with facilitating innovation.
Omair has been an entrepreneur in Biotechnology and Finance, following a 12-year career in Trading and Portfolio Management. He launched a systematic trading firm, premised on his research in chaos theory and patterns.
His transition into Biotech, inspired by medical challenges, was in building and scaling ventures to target pain management with non-opioids and pathogens including SARS-CoV-2 with nanobodies and small molecules. His work was nominated at World Economic Forum COVID-19 Response Challenge in 2020, following his research in Pandemics in 2007.
He obtained a M.Sc. (2013) in Quantitative Finance from London Business School, and BA (Hon) from University of Toronto in Economics, Statistics and Theology.
Karolina has over 12 years of professional experience in international research and innovation cooperation for health and well-being.
She worked for the WHO European Healthy Cities network, leading the WHO Collaborating Centre for Healthy Cities and Urban Health in the Baltic Sea Region, and the Development Manager at MyData Global – an international non-for-profit advocating for a human-centric approach to personal data. When it comes to digital health, she's especially interested in how technology and data can support the sustainable health systems of tomorrow, health literacy and socio-economic determinants of health.
Oleg initiated petition campaign in 251 countries on governments funding fundamental researches & clinical trials on humans(UK), author @LongevityInTime, probably, the largest longevity Telegram channel. Founder of Longevity InTime BioTech (USA) - invented a patent pending AI powered online technology for remote tracking severe diseases on the earliest stages. Believes that "tracking early - live longer" is the best option until now. Assembled like-minded 30+ software developers volunteer team. In the past co-produced award winning Jon Favreau's "Chef" (Scarlett Johansson, Robert Downey Jr., Dustin Hoffman). For 10 years was an advisor to a $1,6B investment banker with $500M worth of deals, incl. Rupert Murdoch's News Outdoor (Russia). Read more
Gerard Gregg-Smith started his career with 10 years in the pharmaceutical industry, initially with Chugai Pharmaceutical (now part of Roche) in Japan, then with Glaxo (now GSK) in the UK. He then worked for 15 years in investment banking (mergers and acquisitions), living and working in three continents, starting with Baring Brothers in London, then Japan for another 5 years, and culminating by joining KPMG Corporate Finance as a Partner.
He then established his own business, GGS Associates, which provides executive search and investor introductions. The executive search focuses on senior appointments, both executive and non-executive in Europe, Asia and the US.
He has raised capital for a number of companies internationally. He is an investor in companies across various sectors, and is available for non-executive roles.
He is a mentor and judge at MassChallenge, Cleantech Challenge, MedTech SuperConnector, Zcube Open Accelerator, and Innovation Forum. He is also an Innovate UK Assessor.